Development Of A Drop-In Purification Step For Removal Of Aggregates From An Antibody Therapeutic
Source: Cytovance Biologics
A client was engaged in large scale cGMP manufacturing operations at a major CMO and their product contained high levels of aggregate following an affinity capture step. Subsequent chromatography steps reduced the aggregate level to acceptable levels but product losses were encountered in elution buffers, and stat in-process assays. Read how they were able to reduce aggregate level and simplify the downstream purification process.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytovance Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more